222 S. Rainbow Blvd
Suite 203
Las Vegas, Nevada 89145

Our Mission

The National Hemophilia Foundation (NHF) Nevada Chapter is dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research.

News & Events

FOR IMMEDIATE RELEASE

MEDIA CONTACT:

Ilana Ostrin

212-328-3769
iostrin@hemophilia.org

Meet NHF's Vice President of Research Strategy, Michelle Witkop! Michelle took her passion for pain management and impactful work and joined NHF. She continues to be a vital part of the NHF community and assisting families and patients. Learn more about her role at NHF and her time working with the community!

Tell us a little bit about yourself and your role at NHF.

Pfizer and Sangamo have announced that recruitment has re-opened for the phase 3 AFFINE study for the investigational gene therapy giroctocogene fitelparvovec. This clinical study is evaluating the efficacy and safety of a single infusion of giroctocogene fitelparvovec in more than 60 adult (ages 18-64 years) participants with moderately severe to severe hemophilia A.

Advertisements

222 S. Rainbow Blvd
Suite 203
Las Vegas, Nevada 89145

© Nevada Chapter of the National Hemophilia Foundation 2022

Crafted by Firespring